These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32118260)

  • 1. Breathalyser-Based eHealth Data Suggest That Self-Reporting of Abstinence Is a Poor Outcome Measure for Alcohol Use Disorder Clinical Trials.
    Hämäläinen MD; Zetterström A; Winkvist M; Söderquist M; Öhagen P; Andersson K; Nyberg F
    Alcohol Alcohol; 2020 Apr; 55(3):237-245. PubMed ID: 32118260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximum Time Between Tests: A Digital Biomarker to Detect Therapy Compliance and Assess Schedule Quality in Measurement-Based eHealth Systems for Alcohol Use Disorder.
    Zetterström A; Hämäläinen MD; Karlberg E; Winkvist M; Söderquist M; Öhagen P; Andersson K; Nyberg F
    Alcohol Alcohol; 2019 Jan; 54(1):70-72. PubMed ID: 30541059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time Monitoring using a breathalyzer-based eHealth system can identify lapse/relapse patterns in alcohol use disorder Patients.
    Hämäläinen MD; Zetterström A; Winkvist M; Söderquist M; Karlberg E; Öhagen P; Andersson K; Nyberg F
    Alcohol Alcohol; 2018 Jul; 53(4):368-375. PubMed ID: 29590325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating Self-Reported Unhealthy Alcohol Use With Phosphatidylethanol (PEth) Among Patients With HIV.
    Eyawo O; Deng Y; Dziura J; Justice AC; McGinnis K; Tate JP; Rodriguez-Barradas MC; Hansen NB; Maisto SA; Marconi VC; O'Connor PG; Bryant K; Fiellin DA; Edelman EJ
    Alcohol Clin Exp Res; 2020 Oct; 44(10):2053-2063. PubMed ID: 33460225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking.
    Wang Y; Chen X; Hahn JA; Brumback B; Zhou Z; Miguez MJ; Cook RL
    Alcohol Clin Exp Res; 2018 Jan; 42(1):128-134. PubMed ID: 29080351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV.
    McGinnis KA; Tate JP; Bryant KJ; Justice AC; O'Connor PG; Rodriguez-Barradas MC; Crystal S; Cutter CJ; Hansen NB; Maisto SA; Marconi VC; Williams EC; Cook RL; Gordon AJ; Gordon KS; Eyawo O; Edelman EJ; Fiellin DA
    AIDS Behav; 2022 Mar; 26(3):786-794. PubMed ID: 34542779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylethanol as an outcome measure in treatment aimed at controlled drinking.
    Hammarberg A; Ingesson Hammarberg S; Redegren Cuellar S; Guterstam J
    Alcohol Alcohol; 2024 Sep; 59(6):. PubMed ID: 39367532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using mobile phone technology to treat alcohol use disorder: study protocol for a randomized controlled trial.
    Danielsson AK; Lundin A; Andréasson S
    Trials; 2018 Dec; 19(1):709. PubMed ID: 30594232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol Use Disorder Treatment: The Association of Pretreatment Use and the Role of Drinking Goal.
    Berger L; Brondino M; Fisher M; Gwyther R; Garbutt JC
    J Am Board Fam Med; 2016; 29(1):37-49. PubMed ID: 26769876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance between timeline follow-back and single-question assessment of self-reported smoking in a clinical trial.
    Bernstein SL; Rosner J; Toll B
    Subst Abus; 2016; 37(3):398-401. PubMed ID: 27007476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of the comparative efficacy of Women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD.
    Zemore SE; Lui C; Mericle A; Hemberg J; Kaskutas LA
    J Subst Abuse Treat; 2018 May; 88():18-26. PubMed ID: 29606223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Social Cognition Deficits Recover with Abstinence in Alcohol-Dependent Patients?
    Rupp CI; Junker D; Kemmler G; Mangweth-Matzek B; Derntl B
    Alcohol Clin Exp Res; 2021 Feb; 45(2):470-479. PubMed ID: 33523497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome in Relation to Drinking Goals in Alcohol-Dependent Individuals: A Follow-up Study 2.5 and 5 Years After Treatment Entry.
    Berglund KJ; Rauwolf KK; Berggren U; Balldin J; Fahlke C
    Alcohol Alcohol; 2019 Jul; 54(4):439-445. PubMed ID: 31053855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning to resist the urge: a double-blind, randomized controlled trial investigating alcohol-specific inhibition training in abstinent patients with alcohol use disorder.
    Tschuemperlin RM; Stein M; Batschelet HM; Moggi F; Soravia LM
    Trials; 2019 Jul; 20(1):402. PubMed ID: 31277683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free-access intravenous alcohol self-administration in social drinkers and individuals with alcohol use disorder: Evaluation of relationships with phosphatidylethanol and self-reported alcohol consumption.
    Olsson Y; Hodzic K; Wass C; Lidö H; Stangl BL; O'Connor S; Plawecki MH; Ramchandani VA; Söderpalm B; Jerlhag E
    Alcohol Clin Exp Res (Hoboken); 2023 Aug; 47(8):1453-1466. PubMed ID: 37331818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the daily reciprocal relations between alcohol abstinence self-efficacy and drinking among non-treatment seeking individuals with alcohol use disorder (AUD).
    Walsh BE; Manzler CA; Noyes ET; Schlauch RC
    Addict Behav; 2024 Sep; 156():108068. PubMed ID: 38772225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of automated smartphone mobile recovery support and telephone continuing care in the treatment of alcohol use disorder: study protocol for a randomized controlled trial.
    McKay JR; Gustafson DH; Ivey M; McTavish F; Pe-Romashko K; Curtis B; Oslin DA; Polsky D; Quanbeck A; Lynch KG
    Trials; 2018 Jan; 19(1):82. PubMed ID: 29382367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using alcohol biosensors and biomarkers to measure changes in drinking: Associations between transdermal alcohol concentration, phosphatidylethanol, and self-report in a contingency management study of persons with and without HIV.
    Richards VL; Wang Y; Porges EC; Gullett JM; Leeman RF; Zhou Z; Barnett NP; Cook RL
    Exp Clin Psychopharmacol; 2023 Dec; 31(6):991-997. PubMed ID: 36649152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of self-reported alcohol use with the alcohol biomarker phosphatidylethanol among young people in northern Tanzania.
    Francis JM; Weiss HA; Helander A; Kapiga SH; Changalucha J; Grosskurth H
    Drug Alcohol Depend; 2015 Nov; 156():289-296. PubMed ID: 26455816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Abstinence During Early Alcohol Treatment is Significantly Associated with Positive Treatment Outcomes, Independent of Duration of Abstinence.
    Dunn KE; Harrison JA; Leoutsakos JM; Han D; Strain EC
    Alcohol Alcohol; 2017 Jan; 52(1):72-79. PubMed ID: 27567268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.